CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 501–600번째 · 6 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100184PPE-conjugated Anti-EPCAM(oportuzumab biosimilar) mAb
  2. BME100185Anti-FZD10(tabituximab biosimilar) mAb
  3. BME100185BBiotinylated Anti-FZD10(tabituximab biosimilar) mAb
  4. BME100185PPE-conjugated Anti-FZD10(tabituximab biosimilar) mAb
  5. BME100186Anti-ALPP(SGN-ALPV biosimilar) mAb
  6. BME100186BBiotinylated Anti-ALPP(SGN-ALPV biosimilar) mAb
  7. BME100186PPE-conjugated Anti-ALPP(SGN-ALPV biosimilar) mAb
  8. BME100187Anti-GPRC5D(LM305 biosimilar) mAb
  9. BME100187BBiotinylated Anti-GPRC5D(LM305 biosimilar) mAb
  10. BME100187PPE-conjugated Anti-GPRC5D(LM305 biosimilar) mAb
  11. BME100188Anti-STEAP1(Vandortuzumab biosimilar) mAb
  12. BME100188BBiotinylated Anti-STEAP1(Vandortuzumab biosimilar) mAb
  13. BME100188PPE-conjugated Anti-STEAP1(Vandortuzumab biosimilar) mAb
  14. BME100189Anti-EPCAM(IMC001 biosimilar) mAb
  15. BME100189BBiotinylated Anti-EPCAM(IMC001 biosimilar) mAb
  16. BME100190Anti-B7-H4(AZD-8205 biosimilar) mAb
  17. BME100190BBiotinylated Anti-B7-H4(AZD-8205 biosimilar) mAb
  18. BME100190PPE-conjugated Anti-B7-H4(AZD-8205 biosimilar) mAb
  19. BME100191Anti-ROR1(NBE 002 biosimilar) mAb
  20. BME100191BBiotinylated Anti-ROR1(NBE 002 biosimilar) mAb
  21. BME100191PPE-conjugated Anti-ROR1(NBE 002 biosimilar) mAb
  22. BME100192Anti-B7-H4(XMT-1660 biosimilar) mAb
  23. BME100192BBiotinylated Anti-B7-H4(XMT-1660 biosimilar) mAb
  24. BME100192PPE-conjugated Anti-B7-H4(XMT-1660 biosimilar) mAb
  25. BME100193Anti-GPRC5D(LBL-034 biosimilar) mAb
  26. BME100193BBiotinylated Anti-GPRC5D(LBL-034 biosimilar) mAb
  27. BME100193PPE-conjugated Anti-GPRC5D(LBL-034 biosimilar) mAb
  28. BME100194Anti-GPNMB(glembatumumab biosimilar) mAb
  29. BME100194BBiotinylated Anti-GPNMB(glembatumumab biosimilar) mAb
  30. BME100194PPE-conjugated Anti-GPNMB(glembatumumab biosimilar) mAb
  31. BME100195Anti-CEACAM5(tusamitamab biosimilar) mAb
  32. BME100195BBiotinylated Anti-CEACAM5(tusamitamab biosimilar) mAb
  33. BME100195PPE-conjugated Anti-CEACAM5(tusamitamab biosimilar) mAb
  34. BME100196Anti-GPRC5D and CD3(LBL-034 biosimilar) BsAb
  35. BME100196BBiotinylated Anti-GPRC5D and CD3(LBL-034 biosimilar) BsAb
  36. BME100196PPE-conjugated Anti-GPRC5D and CD3(LBL-034 biosimilar) BsAb
  37. BME100197Anti-B7-H4(SGN-B7H4V biosimilar) mAb
  38. BME100197BBiotinylated Anti-B7-H4(SGN-B7H4V biosimilar) mAb
  39. BME100197PPE-conjugated Anti-B7-H4(SGN-B7H4V biosimilar) mAb
  40. BME100198Anti-CDH17(ARB102 biosimilar) mAb
  41. BME100198BBiotinylated Anti-CDH17(ARB102 biosimilar) mAb
  42. BME100198PPE-conjugated Anti-CDH17(ARB102 biosimilar) mAb
  43. BME100199Anti-Netrin-1(NP-137 biosimilar) mAb
  44. BME100202Anti-Canine PD-1(INTERVET 4F12) mAb
  45. BME100202BBiotinylated Anti-Canine PD-1(INTERVET 4F12) mAb
  46. BME100202PPE-conjugated Anti-Canine PD-1(INTERVET 4F12) mAb
  47. BME100203Anti-ANGPTL3(evinacumab biosimilar) mAb
  48. BME100203BBiotinylated Anti-ANGPTL3(evinacumab biosimilar) mAb
  49. BME100204Anti-CCR5(leronlimab biosimilar) mAb
  50. BME100204BBiotinylated Anti-CCR5(leronlimab biosimilar) mAb
  51. BME100204PPE-conjugated Anti-CCR5(leronlimab biosimilar) mAb
  52. BME100205Anti-CD14(atibuclimab biosimilar) mAb
  53. BME100205BBiotinylated Anti-CD14(atibuclimab biosimilar) mAb
  54. BME100205PPE-conjugated Anti-CD14(atibuclimab biosimilar) mAb
  55. BME100206Anti-CD19(loncastuximab biosimilar) mAb
  56. BME100206BBiotinylated Anti-CD19(loncastuximab biosimilar) mAb
  57. BME100206PPE-conjugated Anti-CD19(loncastuximab biosimilar) mAb
  58. BME100207Anti-NKG2D(5C5 biosimilar) mAb
  59. BME100207BBiotinylated Anti-NKG2D(5C5 biosimilar) mAb
  60. BME100207PPE-conjugated Anti-NKG2D(5C5 biosimilar) mAb
  61. BME100208Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb
  62. BME100208BBiotinylated Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb
  63. BME100208PPE-conjugated Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb
  64. BME100209Anti-GIPR(maridebart biosimilar) mAb
  65. BME100209BBiotinylated Anti-GIPR(maridebart biosimilar) mAb
  66. BME100209PPE-conjugated Anti-GIPR(maridebart biosimilar) mAb
  67. BME100210Anti-HEL Human IgG1-Kappa Isotype control mAb
  68. BME100210BBiotinylated Anti-HEL Human IgG1-Kappa Isotype control mAb
  69. BME100210PPE-conjugated Anti-HEL Human IgG1-Kappa Isotype control mAb
  70. BME100211Anti-HEL Human IgG2-Kappa Isotype control mAb
  71. BME100211BBiotinylated Anti-HEL Human IgG2-Kappa Isotype control mAb
  72. BME100211PPE-conjugated Anti-HEL Human IgG2-Kappa Isotype control mAb
  73. BME100212Anti-HEL Human IgG4-Kappa Isotype control mAb
  74. BME100212BBiotinylated Anti-HEL Human IgG4-Kappa Isotype control mAb
  75. BME100212PPE-conjugated Anti-HEL Human IgG4-Kappa Isotype control mAb
  76. BME100213Anti-GM-CSFR(mavrilimumab biosimilar) mAb
  77. BME100213BBiotinylated Anti-GM-CSFR(mavrilimumab biosimilar) mAb
  78. BME100213PPE-conjugated Anti-GM-CSFR(mavrilimumab biosimilar) mAb
  79. BME100214Anti-CD6(itolizumab biosimilar) mAb
  80. BME100214BBiotinylated Anti-CD6(itolizumab biosimilar) mAb
  81. BME100214PPE-conjugated Anti-CD6(itolizumab biosimilar) mAb
  82. BME100215Anti-MUC18(AMT 253 biosimilar) mAb
  83. BME100215BBiotinylated Anti-MUC18(AMT 253 biosimilar) mAb
  84. BME100215PPE-conjugated Anti-MUC18(AMT 253 biosimilar) mAb
  85. BME100216Anti-TEM1(ontuxizumab biosimilar) mAb
  86. BME100216BBiotinylated Anti-TEM1(ontuxizumab biosimilar) mAb
  87. BME100216PPE-conjugated Anti-TEM1(ontuxizumab biosimilar) mAb
  88. BME100217Anti-CD73(oleclumab biosimilar) mAb
  89. BME100217BBiotinylated Anti-CD73(oleclumab biosimilar) mAb
  90. BME100217PPE-conjugated Anti-CD73(oleclumab biosimilar) mAb
  91. BME100218Anti-CD73(BMS 986179) mAb
  92. BME100218BBiotinylated Anti-CD73(BMS 986179) mAb
  93. BME100218PPE-conjugated Anti-CD73(BMS 986179) mAb
  94. BME100219Anti-CD39(perenostobart biosimilar) mAb
  95. BME100219BBiotinylated Anti-CD39(perenostobart biosimilar) mAb
  96. BME100219PPE-conjugated Anti-CD39(perenostobart biosimilar) mAb
  97. BME100220Anti-FGFR3(vofatamab biosimilar) mAb
  98. BME100220BBiotinylated Anti-FGFR3(vofatamab biosimilar) mAb
  99. BME100220PPE-conjugated Anti-FGFR3(vofatamab biosimilar) mAb
  100. BME100221Anti-IL5RA(benralizumab biosimilar) mAb